Global Endowment Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Global Endowment Management's LLY Position: Q2 2018 in Review
Global Endowment Management sold out of Eli Lilly (LLY) in Q2 2018, closing a stake of 54,600 shares — an estimated $4.22M sold.
Global Endowment Management first reported a position in LLY in Q3 2016 and held it in 3 quarters. The position peaked at $4.22M in Q1 2018. 1,368 funds tracked by Wall St. Rank hold LLY as of Q2 2018.
- Global Endowment Management reported no remaining Eli Lilly position as of Q2 2018 after selling out during the quarter.
- Global Endowment Management sold 54,600 Eli Lilly shares in Q2 2018, an estimated $4.22M.
- Global Endowment Management first reported a position in Eli Lilly in Q3 2016 and held it in 3 quarters.
- Global Endowment Management's Eli Lilly position peaked at $4.22M in Q1 2018.
- 1,368 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2018.
Based on Global Endowment Management's 13F filing for Q2 2018, filed 10 Aug 2018.